Braunstein Scott

Average Profitability
3.1%
Insider Buys Quantity
2
Insider Buys Sum
$242,840.00
Insider Sells Quantity
5
Insider Sells Sum
$226,295.73

Insider Activity of Braunstein Scott

According to the SEC Form 4 filings, Braunstein Scott, being in a position of

  1. CHAIRMAN AND CEO at Marinus Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 23995 shares for $131,513,
    over all time since 2019-12-13, has bought 100000 shares for $125,000, and sold 30438 shares for $193,025.

The largest purchase of all time was on 2019-12-13 and amounted to 100000 shares of Marinus Pharmaceuticals, Inc. for $125,000.

The largest sale of all time was on 2024-02-16 and amounted to 11850 shares of Marinus Pharmaceuticals, Inc. for $117,789.

Biography of Braunstein Scott

No biography is available at this moment.

2024-08-05SaleMarinus Pharmaceuticals, Inc.
MRNS
CHAIRMAN AND CEO
12,145
0.0227%
$1.13$13,724+33.64%
2024-02-16SaleMarinus Pharmaceuticals, Inc.
MRNS
CHAIRMAN AND CEO
11,850
0.0217%
$9.94$117,789-85.14%
2023-08-08SaleMarinus Pharmaceuticals, Inc.
MRNS
CHAIRMAN AND CEO
30
<0.0001%
$8.94$268-20.88%
2023-08-07SaleMarinus Pharmaceuticals, Inc.
MRNS
CHAIRMAN AND CEO
6,413
0.0133%
$9.55$61,244-22.45%
2019-12-13PurchaseMarinus Pharmaceuticals, Inc.
MRNS
Chief Executive Officer
100,000
0.089%
$1.25$125,000+38.89%
2017-06-05SalePacira BioSciences, Inc.
PCRX
SVP, Strategy & Corp. Dev.
768
0.0019%
$43.32$33,271-16.72%
2016-01-29PurchasePacira BioSciences, Inc.
PCRX
SVP, Strategy & Corp. Dev.
2,000
0.0054%
$58.92$117,840-32.7%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.